Randomised controlled trial
Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial
- Randomised controlled trial
- multicentre
- open-label
- cluster-randomised
Authors' conclusion
Family Heart Talk, a booklet that can be provided to patients with DCM by clinicians with minimal additional time investment, was effective in increasing cardiovascular clinical screening among first-degree relatives of these patients.
Study context
- Population
- Probands with dilated cardiomyopathy and their eligible first-degree relativesprobands randomised
- Participants
- 1,241 probands
- Comparison
- Family Heart Talk booklet vs no booklet
- Family Heart Talkn = 621
- Controln = 620reference
- Primary endpoint
- Completion of screening in eligible first-degree relatives
- Follow-up
- Initiated within 12 months after proband enrollment
Primary result
As reported in the abstract
Screening completion among eligible first-degree relatives
Odds ratio
1.30
95% one-sided CI 1.08-∞
By group
Further findings
Heterogeneity of adjusted OR across race/ethnicity strata (prespecified subgroup)
- No evidence of heterogeneity across race/ethnicity strata
- P = 0.90
Original publication
Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial. Circulation. Published 20 March 2023. doi:10.1161/circulationaha.122.062507
Summarised from the published abstract; every number is checked against it